ALPCO Diagnostics

Executive Summary

ALPCO Diagnostics is a global developer and provider of innovative molecular and immunodiagnostic products, with a focus on automated sample-to-answer solutions for infectious diseases, gastroenterology, and specialty allergy. Founded in 1991 and headquartered in Salem, New Hampshire, the company offers a comprehensive portfolio of instruments, assays, and reagents serving both clinical diagnostics and life science research markets. As a commercial-stage private company, ALPCO distributes its products globally and has established a presence in the diagnostics industry through its specialized offerings. While financial details and recent pipeline developments are not publicly disclosed, the company's long-standing history and niche focus position it as a steady player in the diagnostics space. The absence of disclosed catalysts or public funding rounds suggests a conservative growth trajectory, but its established product portfolio and customer base provide a foundation for continued operations and potential market expansion.